Comparative Efficacy of Dose Regimens in Enzyme Replacement Therapy of Type I Gaucher Disease
Authors:
- R SchiffmannRSR Schiffmann
- C.C ParkerCPC.C Parker
- D.F MooreDMD.F Moore
- C KrepsCKC Kreps
- R.O BradyRBR.O Brady
- N.W BartonNBN.W Barton
- 1 August 2000
- journal article
- clinical trial
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 26 (4) , 285-290
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Effect of Low-dose Enzyme Replacement Therapy on Bones in Gaucher Disease Patients with Severe Skeletal InvolvementBlood Cells, Molecules, and Diseases, 1996
- The Clinical Course of Treated and Untreated Gaucher Disease. A Study of 45 PatientsBlood Cells, Molecules, and Diseases, 1995
- Enzyme replacement treatment in type 1 and type 3 Gaucher's diseaseThe Lancet, 1994
- Glucocerebrosidase for treatment of Gaucher's disease: first German long-term resultsJournal of Hepatology, 1994
- Low‐dose high‐frequency enzyme replacement therapy for very young children with severe Gaucher diseaseBritish Journal of Haematology, 1993
- MRI of Multiple Platyspondyly in Gaucher DiseaseJournal of Computer Assisted Tomography, 1993
- A Less Costly Regimen of Alglucerase to Treat Gaucher's DiseaseNew England Journal of Medicine, 1992
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- Skeletal Complications of Gaucher DiseaseMedicine, 1985
- Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease.Journal of Clinical Investigation, 1966